Singapore markets closed
Straits Times Index
3,336.59 +13.21 (+0.40%) Nikkei
38,487.90 +433.77 (+1.14%) Hang Seng
18,079.61 -150.58 (-0.83%) FTSE 100
8,275.38 +44.33 (+0.54%) Bitcoin USD
67,911.15 +282.66 (+0.42%) CMC Crypto 200
1,421.23 -7.34 (-0.51%)
Revolution Medicines, Inc. (RVMD)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 6.32B |
| Enterprise value | 4.71B |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 1.10k |
| Price/book (mrq) | 3.67 |
| Enterprise value/revenue | 1.03k |
| Enterprise value/EBITDA | N/A |
Trading information
Stock price history
| Beta (5Y monthly) | 1.46 |
| 52-week change 3 | 48.45% |
| S&P500 52-week change 3 | 23.49% |
| 52-week high 3 | 40.63 |
| 52-week low 3 | 15.44 |
| 50-day moving average 3 | 36.01 |
| 200-day moving average 3 | 29.68 |
Share statistics
| Avg vol (3-month) 3 | 1.42M |
| Avg vol (10-day) 3 | 1.3M |
| Shares outstanding 5 | 164.99M |
| Implied shares outstanding 6 | 164.99M |
| Float 8 | 161.17M |
| % held by insiders 1 | 2.37% |
| % held by institutions 1 | 98.80% |
| Shares short (15 May 2024) 4 | 12.94M |
| Short ratio (15 May 2024) 4 | 11.11 |
| Short % of float (15 May 2024) 4 | 8.36% |
| Short % of shares outstanding (15 May 2024) 4 | 7.84% |
| Shares short (prior month 15 Apr 2024) 4 | 12.49M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | -11,550.31% |
Management effectiveness
| Return on assets (ttm) | -22.11% |
| Return on equity (ttm) | -36.17% |
Income statement
| Revenue (ttm) | 4.57M |
| Revenue per share (ttm) | 0.04 |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | N/A |
| EBITDA | -522.04M |
| Net income avi to common (ttm) | -484.27M |
| Diluted EPS (ttm) | -3.84 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 1.7B |
| Total cash per share (mrq) | 10.32 |
| Total debt (mrq) | 88.03M |
| Total debt/equity (mrq) | 5.10% |
| Current ratio (mrq) | 18.45 |
| Book value per share (mrq) | 10.46 |
Cash flow statement
| Operating cash flow (ttm) | -448.74M |
| Levered free cash flow (ttm) | -236.99M |
© 2024 Yahoo. All rights reserved.